Experimental_hepatocellular_carcinoma:_MR_receptor_imaging._Relaxation_time_measurements_and_magnetic_resonance_(MR)_imaging_were_performed_in_three_different_animal_models_of_hepatocellular_carcinoma_(HCC)._After_intravenous_administration_of_asialoglycoprotein-directed_arabinogalactan-stabilized_ultrasmall_superparamagnetic_iron_oxide_(10_mumol_Fe/kg_receptor_agent),_T2_of_normal_liver_decreased_from_41.6_msec_+/-_1.0_to_19.4_msec_+/-_1.7_(P_less_than_.05)_in_rats._T2_of_HCC_implanted_in_normal_liver_or_liver_with_chronic_hepatitis_was_essentially_unchanged._These_results_were_similar_to_those_obtained_by_administration_of_a_reticuloendothelial_cell-directed_conventional_iron_oxide;_however,_the_required_dose_of_receptor_agent_was_lower._MR_imaging_in_a_woodchuck_model_of_virally_induced_HCC_confirmed_the_distribution_of_the_hepatocyte-directed_agent_to_regions_of_functioning_and_differentiated_hepatocytes_but_not_to_malignant_tumor_tissue._The_results_suggest_that_MR_receptor_imaging_may_play_a_role_in_the_differentiation_between_primary_liver_tumor_and_functional_liver_tissue_such_as_that_in_normal_liver_hepatitis_or_regenerating_nodules.